John Wendell's questions to DAXOR (DXR) leadership • Q4 2022
Question
John Wendell commented on the stock's underperformance relative to the company's progress and asked about the potential gross dollar value of a rumored U.S. Army order for 2,000 portable BVA devices.
Answer
CEO Michael Feldschuh addressed the stock price by stating management's focus is on creating long-term fundamental value through operational execution, which he believes will ultimately be reflected in the share price. Regarding the U.S. Army, he clarified that while Daxor is eligible for Phase 3 contracting, he could not comment on the size or value of any potential orders as that information is not public.